Join us for the 2021 Virtual LEAD Webinar Series, where we will explore hot topics in leukemia care, over three virtual, online events. These will be expert-led, collaborative discussions, over topics with particular interest for healthcare professionals managing patients with CML, ALL and AML Don’t miss this opportunity to engage in Q&A with speakers and participate in interactive case studies sessions.
Join us to hear from Professor Jabbour as he shows the prognostic significance of Bone Marrow Blast Counts in R/R B-cell ALL and discusses a patient case regarding how to manage patients with high Bone Marrow Blast Count.
The two sessions will take place at different times so you can attend at a time that is more convenient for you, regardless of your location.
Join us for expert commentary from Dr. Jorge Cortes and Dr. Alexander Lyon on the importance of considering cardiovascular risk in patients with CML. This webinar will review cardiovascular risk assessment as an integral part of collaborative treatment decision-making and use case studies to demonstrate considerations for the long-term management of patients with CML.
Join us to hear from Professor Subklewe and Professor Wang as they discuss how Measurable Residual Disease (MRD) status can help guide your treatment decisions and outcomes for patients eligible for intensive AML treatment and how MRD-negativity is changing the treatment paradigm in AML